Large gap with delayed quotes
Analysis date: 27.10.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 16.10.2026.
Quality
None
None
No stars since 11.09.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 11.09.2026 at a price of 101.30.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 14.08.2026.
4wk Rel Perf
-3.29%
-3.29%
The four-week dividend-adjusted underperformance versus STOXX600 is 3.29%.
Risk
High
High
High, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.34%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.41%.
Mkt Cap in $bn
7.79
7.79
With a market capitalization between $2 & $8bn, ABIVAX is considered a mid-cap stock.
G/PE Ratio
0.16
0.16
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
-77.14
-77.14
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
12.44%
12.44%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
13
13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
108
108
For 1% of index variation, the stock varies on average by 1.08%.
Correlation
0.15
0.15
Stock movements are totally independent of index variations.
Value at Risk
53.32
53.32
The value at risk is estimated at EUR 53.32. The risk is therefore 66.77%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
01.12.2020
01.12.2020